Priority Date: 06.08.12 (US 201261679928P)

METHOD FOR ELICITING IN INFANTS AN IMMUNE RESPONSE AGAINST RSV

  • Application ID: EP13752923
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
3 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). GlaxoSmithKline is specialized in A61. GlaxoSmithKline is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 06.08.2012 - Priority Date (US 201261679928P)
  • 13.02.2014 - Publication A1 (WO2014024024)
  • 10.06.2015 - Publication A1 (EP2879703)

IPC Classification